Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer

Anticancer Research

Volumn 22, Issue 3, 2002, Pages 1813-1817

  Kanoh, Yuhsaku ^a   Akahoshi, Tohru ^a   Ohara, Tadashi ^a   Ohtani, Nobuhisa ^a   Mashiko, Takaomi ^a   Ohtani, Shinichi ^a   Egawa, Shin ^a   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

MMP 2; Prostate cancer (PCa); PSA

Indexed keywords

GELATINASE A; GELATINASE B; PROSTATE SPECIFIC ANTIGEN; STREPTAVIDIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER DIAGNOSIS; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

AGED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0036322562     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma
2. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo
3. Molecular insights into cancer invasion: Strategies for prevention and intervention
4. Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and α2-macrogloburin
5. Fluorogenic MMP activity assay for plasma including MMPs complexed to α2-macrogloburin
6. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2 and TIMP-2 localization
7. Human prostate-specific antigen: Structural and functional similarity with serine proteases
8. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan
9. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas
10. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
11. Levels of α2Macroglobulin can predict bone metastases in prostate cancer
12. Serum prostate specific antigen complex to α1-antichymotrypsin as indicator of prostate cancer
13. Prostate specific antigen-α2-macroglobulin complexes in prostate cancer patient sera
14. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-Kda gelatinase/type IV collagenase) using monoclonal antibodies
15. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis
16. The role of the activated form of matrix metalloproteinase-2 in urothelial cancer
17. Matrix metalloproteinase-9 expression in bladder washes form bladder cancer patients predicts pathological stage and grade
18. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients
19. Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, α2-macroglobulin, and their complexes
20. Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms
21. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia